Cholesterol, often referred to as the silent killer, has long been a focal point in understanding and managing cardiovascular health. Regular cholesterol testing, primarily through lipid panels, has been the cornerstone of preventive care. However, within this realm of cholesterol assessment, a deeper understanding lies in the examination of apolipoproteins and their ratios—offering an advanced perspective on heart health that goes beyond conventional testing.
Traditional lipid panels measure total cholesterol, HDL (high-density lipoprotein), LDL (low-density lipoprotein), and triglyceride levels. While these measurements provide a snapshot of an individual's lipid profile, they don't paint the complete picture of cardiovascular risk. Apolipoproteins, which are proteins involved in transporting cholesterol, specifically Apo A1 and Apo B, play a critical role in understanding this risk.
